SRTS - 2morrowsGains, thanks for the extra color. I can't figure out why the market was so positive on the stock after the previous quarter's earnings (shooting SRTS up to mid $6s) and so harsh this time (taking it down to upper $3s). I may pick up a few shares down here or maybe lower if there's some tax loss selling.
On a personal note: a couple of weeks ago i finished up the nearly 7 week, 13-treatment session course (twice a week) of SRT therapy for a couple of fairly innocuous basal cell skin cancers. I can report that the process is painless; by the end of the course of treatment, you have about a quarter- or fifty-cent-piece coin-size red mark there, nearly to blister point but not quite.
From here on, the spots should recede/shrink as moisturizer is now allowed (not allowed during course of treatment), and, if "before-after" photos of other patients are a reliable indication, in a couple of months the red spots should be almost entirely gone, leaving a much tinier mark than the usual "gouge and stitch (and scarring)" approach that is mainstream in dermatology clinics today.
News 
Market Data 
Discover 
